Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Malaria, COVID-19 and angiotensin-converting enzyme 2: what does the available population data say?

Open biology·2021

Same author

Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model.

Neurotoxicology·2016

Same author

Fungemia due to Trichosporon mucoides in a diabetes mellitus patient: a rare case report.

Indian journal of medical microbiology·2014

Same author

HIV counseling and testing in a tertiary care hospital in Ganjam district, Odisha, India.

Journal of postgraduate medicine·2013

Same author

The year of magical thinking: Joan Didion and the dialectic of grief.

Medical humanities·2013

Same author

Dipylidium caninum infection in a child: a rare case report.

Indian journal of medical microbiology·2013

Search research articles

Related Experiment Video

Updated: May 7, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Drug resistant tuberculosis: a diagnostic challenge.

¹Department of Microbiology, Maharaja Krishna Chandra Gajapati Medical College and Hospital, Berhampur, Odisha, India.

Journal of Postgraduate Medicine

|September 14, 2013

Summary

Drug-resistant tuberculosis (TB) is a growing global threat. This review examines diagnostic options, highlighting the need for rapid methods and strengthened control programs to combat drug-resistant TB.

Area of Science:

Infectious Diseases
Microbiology
Public Health

Background:

Tuberculosis (TB) causes 1.4 million deaths annually.
Widespread anti-tubercular drug misuse has led to global drug-resistant TB (DR-TB), including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).
Accurate and rapid diagnosis of DR-TB is crucial for effective clinical management and infection control.

Purpose of the Study:

To provide an overview of available diagnostic options for drug-resistant TB.
To review recent advancements and challenges in DR-TB diagnostics.
To emphasize the importance of rapid diagnosis in controlling DR-TB.

Main Methods:

Literature search of PubMed for recent articles on drug-resistant TB diagnostics.

Related Experiment Videos

Last Updated: May 7, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Review and synthesis of information on various diagnostic methods.

Analysis of the requirements for implementing new diagnostic technologies.

Main Results:

Phenotypic tests for DR-TB diagnosis are slow, requiring days to weeks for results and necessitating biosafety and quality control.
Newly developed molecular methods offer faster results but require specific infrastructure, trained personnel, and quality assurance.
There is a need for improved diagnostic accessibility and speed to effectively manage DR-TB.

Conclusions:

Global control of drug-resistant TB necessitates strengthening TB control programs.
Wider access to rapid and accurate DR-TB diagnostics is essential.
Political and financial commitment is vital to curb the spread of drug-resistant TB and ensure effective treatment.